The NOFO supports CDC"s efforts to protect U.S. residents traveling internationally. The goal is to help U.S. travelers with pre-travel preparation, access to timely health information while traveling, and timely research on health conditions.The project will:Improve access to high quality travel preparation information for both healthcare providers and travelers.Collect health information before, during, and after travel through innovative electronic medical record (EMR), web, and mobile phone applications.Build on this platform to conduct timely research on emerging health threats.This NOFO will also increase the awareness of travel medicine among primary care providers and provide them with appropriate tools in advising international travelers with up-to-date recommendations.

Young people across Canada are struggling with their mental health with reported increases in anxiety, depression and overall mental or psychological distress 1 . [...] Canadian Institutes of Health Research|Government of Canada

The focus of this notice of funding opportunity (NOFO) is to produce insights into disease detection and prevention strategies, burden, severity, diagnostics, treatment, and outcomes of infectious diseases in international travelers. Timely surveillance and sentinel detection are essential for collecting actionable data. The research should:Address public health questions that improve the speed of outbreak detection.Help develop guidelines and recommendations to improve patient care.Enhance understanding of the natural history of disease.Optimize genomic surveillance as well as diagnostic and treatment strategies.Advance the global health security of the United States.This NOFO will have two components:Component A – Clinic-based sentinel network.Component B – Sentinel detection in inter...

Supports research led by women and people that are gender diverse to address cardiovascular conditions and outcomes that disproportionately affect women and or girls, while strengthening research leadership and capacity in NSW.

Funding opportunity for mid-range capital equipment that will enable and enhance research across MRC’s scientific areas.

Apply for funding to study why people respond differently to biomedical prevention interventions. Projects must generate mechanistic evidence in humans to provide insight into precision prevention through better targeting.

Supports research led by women and people that are gender diverse to address cardiovascular conditions and outcomes that disproportionately affect women and or girls, while strengthening research leadership and capacity in NSW. Program objective Cardiovascular Women's Health Grants aim to: advance gender equity in cardiovascular research and leadership positions address evidence gaps in cardiovascular conditions or outcomes that disproportionately affect women and girls foster research excellence and increase the number of outstanding women and gender diverse cardiovascular researchers in NSW fund research that improves wellbeing and health outcomes for women and girls embed high-quality, innovative cardiovascular research in the NSW health system encourage collaboration, leadership, an...

Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Early Investigator Research Award (EIRA) supports Parkinson’s disease (PD) research for investigators in the early stages of their careers. The FY26 EIRA offers two funding levels, which align to the research career stage of the Principal Investigator (PI). Funding Level 1 (for fellows) requires the investigator to receive guidance from a designated Mentor, whereas Funding Level 2 (for early-career independent investigators) does not. Proposed research must address at least one of the four FY26 PRP Focus Areas.Distinctive Features:·        The Early Investigator is considered the PI of the application and must exhibit strong potential for and commitment to pursuing a career as...

This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding. This NOFO requests limited competition applications for a 3-year extension of the COPE-AKI clinical trial consortium, which includes three clinical centers (CCs) and one scientific and data research center (SDRC), to fully meet the enrollment targets, complete participant follow-up, and provide resources for data analysis and dissemination of study findings. There is currently no standard of care for patients after hosp...

Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Investigator-Initiated Research Award (IIRA) supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to Parkinson’s disease research. Research must address at least one of the four FY26 PRP Focus Areas.Distinctive Features:·        Partnering Principal Investigator (PI) Option: Allows for more than one PI. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. The other PI(s) will be identified as Partnering PI(s), with a maximum of two Partnering PIs.·        Pr...

Elite Researcher Grants aim to promote NSW as a global leader in research by attracting talented researchers to conduct research in NSW. Program objective Conduct pioneering and innovative research and drive discoveries with the long-term aim of improving health and wellbeing. Increase the national and international competitiveness of NSW research. Develop new collaborations and partnerships for research and translation within NSW, Australia and internationally. Support leadership development. Build NSW capacity in a strong, vibrant and highly skilled research workforce. Realise long-term sustained economic impact for NSW. Leverage Australian Government funding opportunities to further research and its translation in NSW. Embed high-quality, innovative research in the NSW health system....

This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite an application from the eligible organization to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, applications will be peer-reviewed, and only meritorious applications will be considered for funding. Through this NOFO, the National institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites an application to continue to follow the Epidemiology of Diabetes Interventions and Complications (EDIC) cohort through a collaborative cooperative agreement that addresses specific knowledge gaps in the development and progression of type 1 diabetes complications. Applications should include hypothesis-based research, support for...

Applications for a 3-year extension/renewal of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) clinical trial consortium are requested to fully meet the enrollment targets, complete participant follow-up, and finalize data analysis and dissemination of study findings. This Notice of Funding Opportunity (NOFO) invites a Single Source application for the eligible organization, the Scientific and Data Research Center (SDRC) already involved in the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Consortium. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered.There is currently no standard of care for p...

This Notice of Funding Opportunity (NOFO) invites applications proposing a Data Coordinating Center that integrates and disseminates multiscale mouse brain datasets for the aging and Alzheimer's disease (AD) research community. The Data Coordinating Center will establish the Aging and AD Mouse Brain Atlas (AD-MBA), which will serve as a central, unified research resource for multi-omic and connectomic mouse brain datasets emerging from the NIA AD Multimodal Atlas Projects (AD-MAPs). The Data Coordinating Center will (1) leverage the NIA-supported AD Knowledge Portal data infrastructure to facilitate hosting, deposition, and dissemination of multimodal datasets generated by the AD-MAPs program, (2) facilitate collaborative analyses among the data-contributing teams, (3) develop/optimize ...

This Notice of Funding Opportunity (NOFO) announces the renewal of the NIH Research Evaluation and Commercialization Hub (REACH) program, established to facilitate and accelerate the translation of academic biomedical discoveries into products that improve patient care and public health. Through this program, NIH will provide the qualifying institutions with the funds to seed the creation of academic entrepreneurship Hubs. Hubs will be responsible for providing innovators with both the initial investment and resources to support the proof-of-concept work and the mentorship in product development and commercialization needed to develop high priority technologies within the NIH's mission. Funded Hubs are intended to work as a consortium to enable: (1) the infrastructure for identifying th...

The purpose of this notice of funding opportunity (NOFO) is to support a Clinical Research Network (CRN) on Antimicrobial Resistance (AMR). The program aims to design, implement, and manage clinical research that addresses pivotal clinical questions related to AMR through a coordinated and integrated CRN. The CRN will comprise four centers: the Scientific Leadership Center (SLC), the Clinical Operations Center (COC), the Laboratory Center (LC), and the Statistics and Data Coordination Center (SDCC).

CIHR's mandate is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health, more effective healt [...] Canadian Institutes of Health Research|Government of Canada

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for an Infectious Diseases Clinical Trials Network (IDCTN). The IDCTN, comprised of the Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), supports the evaluation of interventions for emerging and chronic infections. The CTEUs design and implement clinical trials and studies, while the NCC provides the administrative and operational framework for a collaborative, integrated network and engages with experts in the field to solicit and generate clinical trial concepts. The NCC and CTEUs will collaboratively create opportunities to advance investigators early in their careers and those new to the field.

Apply to the MRC Impact Acceleration Award to address a single, high-risk development step and generate key data to de-risk a new medicine, medical device, diagnostic or other medical product.

The VCGP funds a range of projects that support veteran wellbeing and commemorate and educate NSW communities about the service and sacrifice of current and former military servicemen and servicewomen. Program objective The purpose of the Veteran Community Grants Program (VCGP) is to support activities and services to enhance the wellbeing of the NSW veteran community and promote appreciation and understanding of the service and sacrifice of military service personnel. The VCGP is targeted at individuals and not-for-profit organisations who are based in NSW. Read the Program Guidelines . This program is administered by the NSW Office for Veterans Affairs. This program is administered by Office for Veterans Affairs. Eligibility Who can apply Individuals and the following types of organis...

The objectives of the Partnership Project scheme are to: • Meet the need for more effective integration of research evidence into health policy and service delivery • Create partnerships among policy makers, managers, service providers and researchers  • Provide support to answer often complex and difficult questions that policy makers, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care  • Be highly responsive to the priorities of government, the community and health professionals • Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations.

on projects that: Stream 1 (Targeted Call for Research): conduct clinician researcher-led research within health services to accelerate translation of evidence into practice. Stream 2 (Targeted Call for Research): conduct clinician researcher-led research that strengthens health system performance, workforce innovation and/or service improvement. The intended outcome of the research funded by this grant opportunity is to improve the health and well-being of Australians by supporting nurses, midwives and allied health professionals to improve the quality of health care, practice and systems by undertaking applied research in health care that: improves outcomes for their patients addresses an identified local health priority supports service innovation and improved health system performan...

ance knowledge translation evidence-based structural change in Aboriginal and Torres Strait Islander health practice building on the unique knowledge, strengths and endurance of our communities, with particular reference to Country, culture and spirituality The objective of this grant opportunity is to provide a grant of financial assistance to an organisation or consortium to run an Aboriginal and Torres Strait Islander Community-Controlled program to support Aboriginal and/or Torres Strait Islander led health and medical research projects. The successful applicant is required to undertake a review, develop a Strategic Priorities Investment Plan and partner with and support Aboriginal and Torres Strait Islander health and medical research projects and researchers. This grant opportunit...

Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fund the logical continuation of previous Department of War (DOW)-funded research and development efforts relevant to the FY26 JWMRP that augment and accelerate high-priority medical requirements to meet the needs of Service Members and other Military Health System beneficiaries. The MMRDA supports a wide range of research projects spanning late-stage preclinical studies, late-state technology development efforts, technology demonstration, translational, and clinical research. Projects must be relevant to at least one of the FY26 JWMRP focus areas.Distinctive Features:To be eligible for JWMRP funding, applicants/offerors ...

The CIHR Institute Summer Programs 2027 are intensive 5-day capacity-building programs that aim to provide graduate and post-graduate trainees with advanced training that crosses disciplines, offer [...] Canadian Institutes of Health Research|Government of Canada